.Exelixis is losing hope on its own tissue factor (TF)- targeting antibody-drug conjugate after wrap...
.3 full weeks after Roche's Genentech system left an SHP2 inhibitor contract, Relay Therapeutics has...
.Stoke Rehabs' Dravet syndrome medicine has actually been actually freed from a predisposed grip, cl...
.Fierce Biotech Colleague Editor Gabrielle Masson presented the 2024 training class of Fierce 15 cha...
.Novo Nordisk has actually axed its own once-monthly double GLP-1/ GIP receptor agonist, ending (PDF...
.Merck & Co. has actually rapidly recouped a few of the costs of its own Spear Therapeutics buyou...
.After BioMarin conducted a spring tidy of its pipe in April, the provider has actually chosen that ...
.Major Pharmas remain caught to the idea of molecular adhesive degraders. The latest firm to find a ...
.A new global life scientific research credit rating organization, dubbed Symbiotic Capital, has bro...
.Bristol Myers Squibb is axing an additional large bet coming from the Caforio period, terminating a...